Association Between Antithrombotic Medication Use After Bioprosthetic Aortic Valve Replacement and Outcomes in the Veterans Health Administration System-Reference-Cited by-同舟云学术

Association Between Antithrombotic Medication Use After Bioprosthetic Aortic Valve Replacement and Outcomes in the Veterans Health Administration System

Published:2019-02-20 Issue:2 Volume:154 Page:e184679
ISSN:2168-6254
Container-title:JAMA Surgery
language:en
Short-container-title:JAMA Surg

Author:

Bravata Dawn M.¹²³⁴⁵,Coffing Jessica M.¹,Kansagara Devan⁶⁷⁸⁹,Myers Jennifer¹²,Murphy Lauren¹²⁵,Homoya Barbara J.¹²,Perkins Anthony J.²¹⁰,Snow Kathryn¹,Quin Jacquelyn A.¹¹,Zhang Ying²¹⁰,Myers Laura J.¹²³

Affiliation:

1. Health Services Research and Development, Center for Health Information and Communication, Richard L. Roudebush VA Medical Center, Department of Veterans Affairs, Indianapolis, Indiana

2. Health Services Research and Development, Precision Monitoring to Transform Care, Quality Enhancement Research Initiative, Department of Veterans Affairs, Indianapolis, Indiana

3. Department of Internal Medicine, Indiana University School of Medicine, Indianapolis

4. Department of Neurology, Indiana University School of Medicine, Indianapolis

5. Regenstrief Institute, Indianapolis, Indiana

6. VA Evidence-Based Synthesis Program, Portland, Oregon

7. Department of Internal Medicine, Portland VA Medical Center, Portland, Oregon

8. Department of Internal Medicine, Oregon Health & Science University, Portland

9. Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland

10. Department of Biostatistics, Indiana University School of Medicine, Indianapolis

11. Department of Surgery, VA Boston Healthcare System, West Roxbury, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Surgery

Link

http:///jamasurgery/article-pdf/154/2/e184679/17266784/jamasurgery_bravata_2018_oi_180079.pdf

Reference13 articles.

1. High risk of thromboemboli early after bioprosthetic cardiac valve replacement.;Heras;J Am Coll Cardiol,1995

2. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.;Whitlock;Chest,2012

3. Safety and use of anticoagulation after aortic valve replacement with bioprostheses: a meta-analysis.;Riaz;Circ Cardiovasc Qual Outcomes,2016

4. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?;ElBardissi;J Thorac Cardiovasc Surg,2010

5. Antiplatelet and anticoagulation for patients with prosthetic heart valves.;Massel;Cochrane Database Syst Rev,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of bleeding with concomitant use of oral anticoagulants and aspirin: A systematic review and meta-analysis;American Journal of Health-System Pharmacy;2024-01-23

2. Benefit of Anticoagulation Early After Surgical Aortic Valve Replacement Using Bioprosthetic Valves;Mayo Clinic Proceedings;2023-12

3. Anticoagulation After Bioprosthetic Aortic Valve Replacement: Are We Following the Guidelines?;The Annals of Thoracic Surgery;2023-03

4. A Single-Center Bleeding Comparison of Warfarin Plus Aspirin or Clopidogrel Following Coronary Artery Bypass Grafting and Surgical Valve Replacement;Clinical and Applied Thrombosis/Hemostasis;2023-01

5. Risks and benefits of concurrent treatment with antiplatelet and anticoagulation therapy in post‐op bioprosthetic aortic valve replacement patients;Journal of Cardiac Surgery;2021-01-13